Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome

Annals of the New York Academy of Sciences

Volumn 840, Issue , 1998, Pages 684-697

  Demitrack, Mark A ^a,b   Crofford, Leslie J ^a,b  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR;

CENTRAL NERVOUS SYSTEM; CHRONIC FATIGUE SYNDROME; CONFERENCE PAPER; DEPRESSION; DISEASE COURSE; FATIGUE; FIBROMYALGIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PATHOPHYSIOLOGY; SEROTONINERGIC TRANSMISSION; STRESS; SYMPTOM;

EID: 0032077473     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09607.x     Document Type: Conference Paper

References (61)

1. MANNINGHAM, R. 1750. The Symptoms, Nature, Causes, and Cure of the Febricula, or Little Fever. J Robinson. London.
2. BEARD, G. 1869. Neurasthenia, or Nervous Exhaustion. Boston Med. Surg. J. 111(13): 217-221.
3. VALLEIX, F. Traite des Neuralgies au Affections Douloureuses des Nerfs. 1841; JB Bailliere, Paris.
4. SMYTHE, H. A. & H. MOLDOFSKY. 1977. Two contributions to understanding of the fibrositis syndrome. Bull. Rheum. Dis. 28: 928-931.
5. YUNUS, M. B., A. T. MASI, J. J. CALABRO, K. A. MILLER & S. L. FEIGENBAUM. 1981. Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls. Semin. Arthritis Rheum. 11: 151-171.
6. WOLFE, F., H. A. S.MYTHE, M. B. YUNUS, R. M. BENNETT, C. BOMBARDIER, D. L. GOLDENBERG P. TUGVVELL, S. M. CAMPBELL, M. ABELES, P. CLARK, A. G. FAM, S. J. FARBER, J. J. FIECHTNER, C. M. FRANKLIN, R. A. GATTER, D. HAMATY, J. LESSARD, A. S. LICHTBROUN, A. T. MASI, G. A. McCAIN, W. J. REYNOLDS, T. J. ROMAND, I. J. RUSSELL & R. P. SHEON. 1990. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis Rheum. 33(2): 160-172.
7. FUKUDA, K., S. E. STRAUS, I. HICKIE, M. C. SHARPE, J. G. DOBBINS, A. KOMAROFF & THE INTERNATIONAL CHRONIC FATIGUE SYNDROME STUDY GROUP. 1994. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann. Intern. Med. 121(12): 953-959.
8. GOLDENBERG, D. L. 1991. Fibromyalgia, Chronic Fatigue Syndrome, and Myofascial Pain Syndrome. Curr. Opin. Rheum. 3:247-258.
9. LEDINGHAM, J., S. DOHERTY & M. DOHERTY. 1993. Primary Fibromyalgia Syndrome-An Outcome Study. Br. J. Rheumatol. 32: 139-142.
10. BUCHWALD, D., P. UMAU, J. UMALI, P. KITH, T. PEARLMAN & A. L. KOMAROFF. 1995. Chronic fatigue and the chronic fatigue syndrome: Prevalence in a pacific northwest health care system. Ann. Int. Med. 123: 81-88.
11. KATON, W. & J. Russo. 1992. Chronic fatigue syndrome: A critique of the requirement for multiple physical complaints. Arch. Int. Med. 152: 1604-1609.
12. CATHEY, M. A., F. WOLFE, F. K. ROBERTS, R. M. BENNETT, X. CARO, D. L. GOLDENBERG, I. L. RUSSELL & M. B. YUNUS. 1990. Demographic, Work Disability, Service Utilization and Treatment Characteristics of 260 Fibromyalgia Patients in Rheumatologic Practice. Arthritis Rheum. 33(Suppl.): s10.
13. McCAIN, G. A., R. CAMERON & J. C. KENNEDY. 1989. the problem of long-term disability payments and litigation in primary fibromyalgia: The Canadian perspective. J. Rheumatol. 16(supplement 19): 174-176.
14. BUCHWALD, D., D.L. GOLDENBERG, J. L. SULUVAN & A. L. KOMAROFF. 1987. The 'chronic active Epstein-Barr virus infection' syndrome and primary fibromyalgia. Arthritis Rheum. 30(10): 1132-1136.
15. GOLDENBERG, D. L., R. W. SIMMS, A. GEIGER & A. L. KOMAROFF. 1990. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum. 33(3): 381-387.
16. SCHLUEDERBERG, A., S. E. STRAUS, P. PETERSON, S. BLUMENTHAL, A. L. KOMAROFF, S. B. SPRING, A. LANDAY & D. BUCHWALD. 1992. Chronic fatigue syndrome research. Definition and medical outcome assessment. Ann. Int. Med. 117(4): 325-331.
17. HUDSON, J. I., D. L. GOLDENBERG, ,H. G. POPE, P. E. KECK & L. SCHLESINGER. 1992. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am. J. Med. 92: 363-367.
18. DEMITRACK, M. A., J. K. DALE, S. E. STRAUS, L. LAUE, S. J. LISTWAK, M. J. P. KRUESI, G. P. CHROUSOS & P. W. GOLD. 1991. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endo. Metab. 73(6): 1224-1234.
19. SWANSON, L. W., P. E. SAWCHENKO, J. RWIER, & W. W. VALE. 1983. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain. An immunohistochemical study. Neuroendocrinology 36: 165-186.
20. VALE, W, J. VAUGHAN, M. SMITH, G. YAMAMOTO, J. RIVIER & C. RIVIER. 1983. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Endocrinology. 113: 1121-1131.
21. DEKLOET, R., G. WALLACH & B. S. MCEWEN. 1975. Differences in corticosterone and dexmethasone binding to rat brain and pituitary. Endocrinology 76: 598-609.
22. HERMAN J. P., S. WIEGAND & S. J. WATSON. 1990. Regulation of basal corticotropin releasing hormone and arginine vasopressin mRNA expression in the paraventricular nucleus: Effects of selective hypothalamic deafferentation. Endocrinology 127: 2408-2417.
23. KRIEGER, D. T. 1979. Rhythms in CRH, ACTH and corticosteroids. Endocr. Rev. 1: 123.
24. NIEMAN, L. K., G. P. CHROUSOS, H. M. SCHULTE, D. L. LORIAUX, & B. C. NISULA. 1984. Adrenal regulation of corticosteroid binding globulin. In International Congress Series. 652: 1096. Abstract 1672A, Excerpta Medica. Elsevier Biomedical Press. New York.
25. GOLD, P. W, D. L. LORIAUX, A. ROY, M. A. KUNG, J. R. CALABRESE, C. H. KELLNER, L. K. NIEMAN, R. M. POST, D. PICKAR, W. T. GALLUCCI, P. AVGERINOS, S. PAUL, E. H. OLDFIELD, G. B. CUTLER, JR. & G. P. CHROUSOS. 1986. Responses to Corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease: Pathophysiologic and diagnostic implications. N. Engl. J. Med. 314(21): 1329-1334.
26. HOLSBOER, F., U. VONBARDELBEN, A. GERKEN, G. K. STALLER & O. A. MULLER. 1984. Blunted corticotropin and normal Cortisol reponse to human corticotropin-releasing factor in depression. N. Engl. J. Med. 31: 1127.
27. GOLD, P. W., H. GWIRTSMAN, P. C. AVGERINOS, L. K. NIEMAN, W. T. GALLUCCI, W. KAYE, D. JMERSON, M. EBEKT, R. RITTMASTER, D. L. LORIAUX & G. P. CHROUSOS. 1986. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa: Pathophysiologic mechanisms in underweight and weight-corrected patients. N. Engl. J. Med. 314(21): 1335-1342.
28. AVGERINOS, P. C., G. P. CHROUSOS, L. K. NIEMAN, E. H. OLDFIELD, D. L. LORIAUX & G. B. CUTLER. 1987. The corticotropin-releasing hormone test in the postoperative evaluation of patients with Cushing's syndrome. J. Clin. Endocrinol. Metab. 65(5): 906-913.
29. MULLER, O. A., G. K. STALLER & K. VON WERDER. 1987. Corticotropin-releasing factor in humans II. CRF stimulation in patients with diseases of the hypothalamic-pituitaryadrenal axis. Horm. Res. 25: 185-198.
30. KUNG, M. A., A. ROY, A. R. DORAN, J. R. CALAERESE, D. R. RUBINOW, H. J. WHITFIELD, JR., C. MAY, R. M. POST, G. P. CHROUSOS & P. W. GOLD. 1991. Cerebrospinal fluid immunoreactive CRH and ACTH secretion in Cushing's disease and major depression: Potential Clinical Implications. J. Clin. Endocrinol. Metab. 72(2): 2 60-271.
31. TOMORI, N., S. SUDA, F. TOZAWA, H. DEMURA, K. SHIZUME & T. MOURI. 1983. Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders. J. Clin. Endocrinol. Metab. 56(6): 1305-1307.
32. GARRICK, N. A., J. L. HILL, F. G. SZELE, T. P. TOMAI & P. W. GOLD. 1987. Corticotropinreleasing factor: A marked circadian rhythm in primate cerebrospinal fluid peaks in the evening and is inversely related to the cortisol circadian rhythm. Endocrinology 121: 1329-1334.
33. CARNES, M., C. M. BARKSDALE, N. H. KALIN, M. S. BROWNFIELD & S. J. LENT. 1987. Effect of dexamethasone on central and peripheral ACTH systems in the rat. Neuroendocrinology 45: 160-164.
34. CROFFORD, L. J., S. R. PILLEMER, K. T. KALOGERAS, J. M. CASH, D. MICHELSON, M. A. KUNG, E. M. STERNBERG, P. W. GOLD, G. P. CHROUSOS & R. L. WILDER. 1994. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum. 37: 1583-1592.
35. McCAIN, G. A. & K. S. TILBE. 1989. Diurnal hormone variation in fibromyalgia syndrome: A comparison with rheumatoid arthritis. J. Rheum. 16(Suppl 19): 154-157.
36. GRIEP, E. N., J. W. BOERSMA & E. R. DEKLOET. 1993. Altered reactivity of the hypothalamicpituitary-adrenal axis in the primary fibromyalgia syndrome. J. Rheum. 20: 469-174.
37. HARBUZ, M. S., R. G. REE, D. ECHLAND, D. S. JESSOP, D. BREWERTON, S. L. LIGHTMAN. 1992. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanacortin mRNA during chronic inflammatory stress. Endocrinology 130: 1394-1400.
38. PATCHEV, V. K., K. T. KALOGERAS, P. ZEALZOWSKI, R. L. WILDER & G. P. CHROUSOS. 1992. Increased plasma concentration, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats. Endocrinology 131:1453-1457.
39. BAKHEIT, A. M. O., P. O. BEHAN, W. S. WATSON & J. J. MORTON. 1993. Abnormal arginine vasopressin secretion and water metabolism in patients with postviral fatigue syndrome. Acta Neurol. Scand. 87: 234-238.
40. SACHAR, E. J., L. HELLMAN, H. P. ROFFWARG, F. S. HALPERN, D. K. FUKUSH & T. F. GALLAGHER. 1973. Disrupted 24-hour patterns of cortisol secretion in psychotic depressives. Arch. Gen. Psychiatry 28: 19-24.
41. POTEUAKHOFF, A. 1981. Adrcnocortical activity and some clinical findings in acute and chronic fatigue. J. Psychosom. Res. 25: 91-95.
42. HUDSON, J. I., L. F. PLINER, M. S. HUDSON, D. L. GOLDENBERG & J. C. MELBY. 1984. The dexamethasone suppression test in fibrositis. Biol. Psychiatry 19:1489-1493.
43. FERRACCIOLI, G., F. CAVALIERI, F. SALAFFI, S. FONTANA, F. SCFTA, M. NOLU & D. MAESTRI. 1990. Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain. J. Rheum. 19:869-873.
44. CLEARE, A. J., J. BEARN, T. ALLALM, A. MACGREGOR, S. WESSELY, R. M. MURRAY & V. O'KEANE. 1995. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J. Aff. Dis. 35: 283-289.
45. TOBI, M., A. MORAG, Z. RAVID, I. CHOWERS, V. FELDMAN-WEISS, Y. MICHAELI, E. BENCHITRIT, M. SHAUT & H. KNOBLER. 1982. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet i: 61-64.
46. JONES, J. F., G. RAY, L. L. MINNICH, M. J. HICKS, R. KIELER, D. O. LUCAS. 1985. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann. Int. Med. 102(1): 1-7.
47. STRAUS, S. E., G. TOSATO, G. ARMSTRONG, T. LAWLEY, D. T. PREBLE, W. HENLE, R. DAVEY, G. PEARSON, J. EPSTEIN, I. BRUS & R.M. BLAESE. 1985. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann. Int. Med. 102(1): 7-16.
48. CHENEY, P. R., S. E. DORMAN & D. S. BELL. 1989. Interleukin-2 and the chronic fatigue syndrome. Ann. Int. Med. 110: 321.
49. CHAD, C. C., M. GALLAGHER, J. PHAIR & P. K. PETERSON. 1990. Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J. Inf. Dis. 162: 1412-1413.
50. LANDAY, A. L., C. JESSOP, E. T. LENNETTE & J. A. LEVY. 1991. Chronic fatigue syndrome: Clinical condition associated with immune activation. Lancet 338(8769): 707-712.
51. FRITZ, S., J. DALE, B. GOULD, W. STROBER & S. E. STRAUS. 1992. Lymphocyte phenotype analysis suggests chronic immune stimulation in patients with chronic fatigue syndrome. J. Clin. Immunol.
52. HEYES, M. P., K. SAITO, J. CROWLEY, L. E. DAVIS, M. A. DEMITRACK, M. DER, M. J. P. KRUESI, A. LACKNER, S. A. LARSEN, K. LEE, H. LEONARD, A. MARTIN, S. P. MARKEY, S. MILSTEIN, M. M. MOURSADIAN, M. R. PRANZANELLI, B. J. QUEARRY, J. L. RAPOPORT, A. SALAZAR, M. SMITH, S. E. STRAUS, T. SUNDERLAND, S. SWEDO & W. W. TOUTELLOTTE. 1992. Neuroactive kynuerines in cerebral and meningeal infections, sepsis, neuropsychiatric disorders and chronic neurodegenerative diseases of man. Brain.
53. CARD, X. J. 1989. Is there an immunologic component to the fibrositis syndrome? Rheum. Dis. Clin. N. Am. 15(1): 169-186.
54. STERNBERG, E. M., J. M. HILL, G. P. CHROUSOS, T. KAMILARIS, S. J. LISTWAK, P. W. GOLD & R. L. WILDER. 1989. Inflammatory mediator-induced hypothalamic-pituitary-adrenal activation is defective in streptococcal cell wall arthritis-susceptible rats. Proc. Natl. Acad. Sci. USA 86: 2374-2378.
55. STERNBERG, E. M., W. S. YOUNG III, R. BERNARDINI, A. E. CALOGERO, G. P. CHROUSOS, P. W. GOLD & R. L. WILDER. 1989. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. USA 86: 4771-4775.
56. TAKASU, N., I. KOMIYA, Y. NAGASAWA, T. ASAWA & T. YAMADA. 1990. Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma. N. Engl. J. Med. 322(24): 1708-1712.
57. DIXON, R. B. & N. P. CHRISTY. 1980. On the various forms of corticosteroid withdrawal syndrome. Am. J. Med. 68(2): 224-230.
58. DISDIER, P., J-R. HARLE, T. BRUE, P. JAQUET, P. CHAMBOURUER, F. GRISOLL, P-J. WEILLER. 1991. Severe fibromyalgia after hypophysectomy for Cushing's disease. Arthritis and Rheum. 34(4): 493-495.
59. BROWN, M. R., L. A. FISHER, J. SPIESS, C. RIVIER, J. RIVIER & W. VALE. 1982. Corticotropinreleasing factor: Actions on the sympathetic nervous system and metabolism. Endocrinology 111: 928-931.
60. SWERDLOW, N. R., M. A. GEYER, W. W. VALE & G. F. KOOB. 1986. Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide. Psychopharmacology (Berlin) 88:147-152.
61. SUTTON, R. E., G. F. KOOB, M. LEMOAL, J. RIVIER & W. VALE. 1982. Corticotropin-releasing factor produces behavioural activation in rats. Nature 297:331-333.